Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Why Predictive Oncology Stock Is Getting Hammered

Predictive Oncology Inc (NASDAQ: POAI) shares are trading lower by 15.81% to $0.23 Friday morning after the company announced a reverse stock split. What Else? Per an SEC filing, the reverse stock split will become effective at 12:01 a.m. on Monday, April 24.
byHenry Khederian
April 21, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Predictive Oncology Inc (NASDAQ:POAI) shares are trading lower by 15.81% to $0.23 Friday morning after the company announced a reverse stock split.

What Else?

Per an SEC filing, the reverse stock split will become effective at 12:01 a.m. on Monday, April 24.

Every 20 shares of Predictive Oncology’s issued and outstanding common stock will be converted automatically into one issued and outstanding share of common stock.

See Also: SLB Q1 Results Beat Analyst Expectations, Records 30% Revenue Growth

Predictive Oncology says the reverse stock split is primarily intended to bring the company into compliance with the minimum bid price requirement to maintain the listing of the company’s common stock on the Nasdaq Capital Market.

According to data from Benzinga Pro, POAI has a 52-week high of $0.80 and a 52-week low of $0.21.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Asia Markets Recover, Eurozone Trades Mixed, Crude Breaches $85 – Global Markets Today While US Was Sleeping

By Akanksha Bakshi
October 5, 7:06 AM
On Wednesday, October 4, the U.S. stock markets ended higher, led by tech-focused Nasdaq Composite, influenced by the September private payrolls data rising below expectations. Private payrolls increased by 89,000 in September, significantly falling short of the anticipated 153,000 and down from 180,000 in August, as per the ADP and Moody’s Analytics report.

ADIV